Afya Limited SEC filings document the company as a foreign private issuer reporting on Form 6-K and presenting financial information in Brazilian reais under IFRS. The filings include unaudited interim and annual consolidated financial statements, operating-result releases and balance-sheet disclosures covering cash, receivables, property and equipment, right-of-use assets, intangible assets, loans and financing, lease liabilities and accounts payable to selling shareholders.
The filing record also documents Afya’s capital-allocation actions, including dividend approvals and share repurchase disclosures, as well as medical-seat authorizations for Brazilian campuses and board-governance changes. These reports connect Afya’s education and medical practice solutions business with formal disclosures on capital structure, liquidity, campus approvals, ownership-related obligations and governance matters.
Afya Ltd vice president Junior Lelio de Souza reported an open-market sale of 36,204 Class A Common Shares on July 1, 2026. The shares were sold at a price of $15.00 per share. Following this transaction, he reported owning no Class A Common Shares directly.
Afya Ltd vice president Mirella Basolli Gomiero reported an open-market sale of 10,000 Class A common shares at $14.80 per share. After this transaction, she directly holds 34,530 Class A common shares.
Afya Ltd Vice President Junior Lelio de Souza sold 41,541 Class A common shares at $15.00 per share in an open-market transaction. After this sale, he directly holds 36,204 Class A common shares. This Form 4 reflects a sizable discretionary reduction while leaving a meaningful remaining stake.
Afya Limited reported the result of its Annual General Meeting held on June 22, 2026. Shareholders approved and ratified Afya’s financial statements for the fiscal year ended December 31, 2025, as set out in the Notice of Annual General Meeting dated June 2, 2026.
Afya describes itself as a leading medical education group in Brazil, offering an end-to-end, physician‑centric ecosystem that supports students and doctors from medical school admission through residency preparation, continuing education and medical practice solutions.
Afya Ltd’s controlling shareholder Bertelsmann SE & Co. KGaA and its subsidiary Erste WV Gutersloh GmbH report updated ownership under Amendment No. 34 to their Schedule 13D. They purchased an additional 425,367 Class A common shares under a Trading Plan for a total of $7,358,766.71, or an average of $17.30 per share, funded with internally generated cash.
Following these open-market purchases, the reporting group is the beneficial owner of 27,001,946 Class A common shares, representing 53.54% of the 50,437,186 Class A shares outstanding as of March 31, 2026. Including 34,074,134 Class B shares (convertible one-for-one into Class A), they beneficially own 61,076,080 shares in total, or 72.27% of Afya on an as-converted basis, with Class B shares carrying ten votes per share.
Afya Limited filed a Form 144 reporting proposed sales of Class A common shares by an affiliate, listing recent dispositions and securities eligible for sale. The filing shows two sales in the past three months by Lelio de Souza Junior of 26,753 shares for $399,957.35 and 16,279 shares for $236,533.87. The filing also lists quantities of Class A shares tied to equity compensation: 66,000 shares (acquired pursuant to a Stock Option Plan under an S-8) and 11,745 shares (acquired pursuant to a Restricted Share Units Program).
Afya Limited has called its 2026 Annual General Meeting for June 22, 2026 at 10:00 a.m. BRT, to be held in Belo Horizonte, Brazil and virtually. Shareholders of record as of May 15, 2026 are entitled to receive notice and vote.
The main item of business is to ratify and approve Afya’s 2025 financial statements and the auditor’s report for the year ended December 31, 2025, prepared under IFRS. Each Class A common and Class A restricted share carries one vote, while each Class B common share carries ten votes.
As of the record date, Afya had 93,722,831 common shares issued and outstanding across its three share classes. The board of directors recommends that shareholders vote “FOR” the ratification proposal and is soliciting proxies via internet, mobile and mailed proxy cards to ensure broad participation.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported a set of equity compensation transactions involving Class A common shares and restricted stock units (RSUs) on May 7, 2026.
He exercised derivative awards to acquire a total of 59,000 Class A common shares, and a separate transaction shows 16,225 shares withheld at $14.41 per share to cover tax obligations, a non-market “F” code disposition. Following these transactions, he directly owns 151,223 Class A common shares and indirectly holds 200,000 Class A common shares through GIBBOAT OVERSEAS LTD, which he solely owns and controls. Footnotes state that RSUs convert into common shares on a one-for-one basis, have no expiration date, and either fully vested on May 5, 2026 or will vest in annual tranches from 2027 to 2029 subject to his continued service.
Afya Ltd Vice President Denis Del Bianco reported routine equity compensation activity. He exercised derivative awards to acquire 21,900 Class A common shares and had 6,023 shares withheld at $14.41 per share to cover tax obligations, a non‑market “F” tax-withholding disposition. Following these transactions, he directly held 25,422 Class A common shares. Related restricted stock units convert into common shares on a one-for-one basis, with portions vesting on specified dates through May 2029 subject to continued service.
Afya Ltd Vice President Mirella Basolli Gomiero reported routine equity compensation activity. On May 7, 2026 she exercised 12,780 restricted stock units into Class A common shares, and 3,515 shares were disposed of to cover tax obligations. Following these transactions, she holds 44,530 Class A common shares directly and 17,040 RSUs that continue to vest through May 1, 2027.